This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Alex Zvulunov, MD
Department of Dermatology Soroka Medical Center Beer-Sheva 84101, Israel

Arch Dermatol. 1996;132(6):712-713.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

I read with great interest the editorial comments by Riccardi¹ on the possible research implications of the article recently published by my colleagues and myself.² However, I was confused by the notion of "the lack of an excess of inherited cases among patients with the triad of NF-1, JXG, and JCML." Our study showed a significant excess of familial neurofibromatosis type 1 (NF-1) among patients with the triad compared with patients with NF-1 and juvenile xanthogranuloma (JXG) but without juvenile chronic myelogenous leukemia (JCML) (85% vs 47%, P<.003). As I read further about "the canceling out of this excess [male preponderance] when the triad is present," the source of this and the previous misinterpretation has become obvious. The error was found in the labeling of two columns in Table 3 in the published article (Table, corrected); the column labeled JXG+NF+JCML and the corresponding footnote should now be . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?